These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30726463)

  • 1. Association between tumor-infiltrating lymphocytes and sentinel lymph node positivity in thin melanoma.
    Santos FMD; Silva FCD; Pedron J; Furian RD; Fortes C; Bonamigo RR
    An Bras Dermatol; 2019; 94(1):47-51. PubMed ID: 30726463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
    Appleton SE; Fadel Z; Williams JS; Bezuhly M
    Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to Procedure, Nuclear Imaging and Clinicopathological Characteristics as Predictive Factors for Sentinel Lymph Node Metastasis in Cutaneous Melanoma: A Single-Center Analysis.
    Jaukovic L; Rajović M; Kandolf Sekulovic L; Radulovic M; Stepic N; Mijuskovic Z; Petrov N; Ajdinovic B
    Ann Plast Surg; 2018 Jul; 81(1):80-86. PubMed ID: 29762449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
    Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
    Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
    Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
    Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression and Sentinel Lymph Node Status in Melanoma Progression.
    Letca AF; Ungureanu L; Şenilă SC; Grigore LE; Pop Ş; Fechete O; Vesa ŞC; Cosgarea R
    Med Sci Monit; 2018 Mar; 24():1359-1365. PubMed ID: 29507279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transected thin melanoma: Implications for sentinel lymph node staging.
    Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
    J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
    Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
    Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: a single institution experience.
    Homolak D; Šitum M; Čupić H
    Acta Dermatovenerol Croat; 2015; 23(2):122-9. PubMed ID: 26228823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroscopic tumor dimension, sentinel lymph node outcome, and survival analysis among cutaneous melanoma.
    Asato MA; Moraes-Neto FA; Moraes MPT; Ocanha-Xavier JP; Alencar Marques ME; Xavier-Junior JCC
    Int J Dermatol; 2024 Jun; 63(6):765-772. PubMed ID: 38217520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
    Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
    Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy in Merkel cell carcinoma: Predictors of sentinel lymph node positivity and association with overall survival.
    Conic RRZ; Ko J; Saridakis S; Damiani G; Funchain P; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Aug; 81(2):364-372. PubMed ID: 30902726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases.
    Piazzalunga D; Ceresoli M; Allievi N; Ribero S; Quaglino P; Di Lorenzo S; Corradino B; Campana LG; Mocellin S; Rossi CR;
    Eur J Surg Oncol; 2019 May; 45(5):820-824. PubMed ID: 30527782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.